SCHEMBL23488362

SCHEMBL23488362

NC(=O)c1cc(OCc2ccccc2)ccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.56
OPRK1 P41145 1/20 0.55
KCNH2 Q12809 1/20 0.55
PLAU P00749 1/20 0.52
PLAT P00750 1/20 0.52
NR4A2 P43354 2/20 0.51
KMT2A Q03164 2/20 0.50
P4HTM Q9NXG6 1/20 0.50
MEN1 O00255 1/20 0.50
SIRT2 Q8IXJ6 1/20 0.49
SPHK2 Q9NRA0 2/20 0.49
SPHK1 Q9NYA1 1/20 0.49
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
PKM P14618 1/20 0.49
MAOB P27338 3/20 0.49
NR4A1 P22736 1/20 0.47
NR4A3 Q92570 1/20 0.47
LNPEP Q9UIQ6 1/20 0.47
CYP4F2 P78329 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4359501 0.90 PARP10 (0.57) PARP10OPRK1KCNH2PLAUPLAT
SCHEMBL11617562 0.88 P4HTM (0.60) PLAUPLATNR4A2KMT2AP4HTM
SCHEMBL6819358 0.84 NR4A2 (0.50) PLAUPLATNR4A2KMT2AP4HTM
SCHEMBL20510001 0.82 LMNA (0.52) NR4A2KMT2AP4HTMMEN1ALDH1A1
SCHEMBL18681644 0.81 CSF1R (0.54) NR4A2KMT2AP4HTMMEN1MAOB
SCHEMBL4155509 0.80 PARP10 (0.51) PARP10OPRK1KCNH2SIRT2
SCHEMBL29149631 0.79 PLAU (0.50) PARP10PLAUPLATNR4A2KMT2A
SCHEMBL4364055 0.78 MCL1 (0.59) PARP10NR4A2KMT2AP4HTMMEN1
SCHEMBL20812637 0.78 ANO1 (0.53) KMT2AMEN1KDM4EMAOBSMPD1
SCHEMBL19859615 0.78 MAOB (0.46) NR4A2KMT2AP4HTMMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 PARP10 1135/4885OPRK1 3313/4885KCNH2 4557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.